
Sophia S. Chen
Examiner (ID: 4164, Phone: (571)272-2133 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2809, 2105, 2852 |
| Total Applications | 3623 |
| Issued Applications | 3447 |
| Pending Applications | 91 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5148214
[patent_doc_number] => 20070048270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'METHODS OF TREATING CANCER USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 11/548585
[patent_app_country] => US
[patent_app_date] => 2006-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49594
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548585 | METHODS OF TREATING CANCER USING IL-21 | Oct 10, 2006 | Abandoned |
Array
(
[id] => 4999306
[patent_doc_number] => 20070041940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'METHODS OF TREATING CANCER USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 11/548530
[patent_app_country] => US
[patent_app_date] => 2006-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49647
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548530
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548530 | METHODS OF TREATING CANCER USING IL-21 | Oct 10, 2006 | Abandoned |
Array
(
[id] => 5148211
[patent_doc_number] => 20070048267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'METHODS OF TREATING CANCER USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 11/548202
[patent_app_country] => US
[patent_app_date] => 2006-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49599
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048267.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548202 | METHODS OF TREATING CANCER USING IL-21 | Oct 9, 2006 | Abandoned |
Array
(
[id] => 5148210
[patent_doc_number] => 20070048266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'METHODS OF TREATING CANCER USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 11/548196
[patent_app_country] => US
[patent_app_date] => 2006-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49602
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048266.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548196 | METHODS OF TREATING CANCER USING IL-21 | Oct 9, 2006 | Abandoned |
Array
(
[id] => 9710822
[patent_doc_number] => 08835390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Modulation of osteoclast differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/992234
[patent_app_country] => US
[patent_app_date] => 2006-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 6300
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992234 | Modulation of osteoclast differentiation | Sep 18, 2006 | Issued |
Array
(
[id] => 232632
[patent_doc_number] => 07598057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Use of cytokine receptors as biomarkers and therapeutic targets in human cancer'
[patent_app_type] => utility
[patent_app_number] => 11/512501
[patent_app_country] => US
[patent_app_date] => 2006-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4943
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598057.pdf
[firstpage_image] =>[orig_patent_app_number] => 11512501
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/512501 | Use of cytokine receptors as biomarkers and therapeutic targets in human cancer | Aug 29, 2006 | Issued |
Array
(
[id] => 9922316
[patent_doc_number] => 08980272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Antibody targeting osteoclast-associated protein'
[patent_app_type] => utility
[patent_app_number] => 11/503574
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33957
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11503574
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503574 | Antibody targeting osteoclast-associated protein | Aug 10, 2006 | Issued |
Array
(
[id] => 5075221
[patent_doc_number] => 20070015196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Growth factor with acts through Erb B-4 RTK'
[patent_app_type] => utility
[patent_app_number] => 11/492124
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 35955
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492124 | Growth factor with acts through Erb B-4 RTK | Jul 24, 2006 | Abandoned |
Array
(
[id] => 5852013
[patent_doc_number] => 20060235204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'BMP-2 variants with improved properties'
[patent_app_type] => utility
[patent_app_number] => 11/471893
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 39923
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471893 | BMP-2 variants with improved properties | Jun 19, 2006 | Abandoned |
Array
(
[id] => 4922521
[patent_doc_number] => 20080070837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'BMP-4 variants with improved properties'
[patent_app_type] => utility
[patent_app_number] => 11/471957
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 41456
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070837.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471957
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471957 | BMP-4 variants with improved properties | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5760903
[patent_doc_number] => 20060211848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses'
[patent_app_type] => utility
[patent_app_number] => 11/441587
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 31292
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211848.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441587
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441587 | Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses | May 25, 2006 | Abandoned |
Array
(
[id] => 5835370
[patent_doc_number] => 20060247201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Myeloid colony stimulating factor and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/431181
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6456
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431181 | Myeloid colony stimulating factor and uses thereof | May 8, 2006 | Issued |
Array
(
[id] => 4572472
[patent_doc_number] => 07833270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-16
[patent_title] => 'Implant depots to deliver growth factors to treat osteoporotic bone'
[patent_app_type] => utility
[patent_app_number] => 11/418947
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4267
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/833/07833270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418947 | Implant depots to deliver growth factors to treat osteoporotic bone | May 4, 2006 | Issued |
Array
(
[id] => 4623813
[patent_doc_number] => 08003108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Sclerostin epitopes'
[patent_app_type] => utility
[patent_app_number] => 11/410540
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 51225
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003108.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410540 | Sclerostin epitopes | Apr 24, 2006 | Issued |
Array
(
[id] => 5672552
[patent_doc_number] => 20060177907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods and materials for characterizing and modulating interaction between heregulin and HER3'
[patent_app_type] => utility
[patent_app_number] => 11/406679
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27390
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11406679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/406679 | Methods and materials for characterizing and modulating interaction between heregulin and HER3 | Apr 18, 2006 | Issued |
Array
(
[id] => 8006045
[patent_doc_number] => 08084423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/405601
[patent_app_country] => US
[patent_app_date] => 2006-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 17055
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084423.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405601 | Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use | Apr 16, 2006 | Issued |
Array
(
[id] => 5125531
[patent_doc_number] => 20070237802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Inhibition of Calcification on an Endovascular Device'
[patent_app_type] => utility
[patent_app_number] => 11/279325
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3230
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279325
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279325 | Inhibition of Calcification on an Endovascular Device | Apr 10, 2006 | Abandoned |
Array
(
[id] => 5682550
[patent_doc_number] => 20060198820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders'
[patent_app_type] => utility
[patent_app_number] => 11/361977
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 51351
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361977
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361977 | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders | Feb 23, 2006 | Abandoned |
Array
(
[id] => 5656462
[patent_doc_number] => 20060142198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Compositions for treating wounds and processes for their preparation'
[patent_app_type] => utility
[patent_app_number] => 11/357707
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11037
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357707
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357707 | Compositions for treating wounds and processes for their preparation | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5596819
[patent_doc_number] => 20060160737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Methods of using IL-1 antagonists to treat polymyalgia rheumatica and giant cell arteritis'
[patent_app_type] => utility
[patent_app_number] => 11/332434
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6898
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332434 | Methods of using IL-1 antagonists to treat polymyalgia rheumatica and giant cell arteritis | Jan 12, 2006 | Abandoned |